The Philippines' Department of Health (DOH) announced on June 12 that patients in Metro Manila can now access free medications for mental ...

Vietnam abolished its long-running two-child policy in June 2025 after decades of strict enforcement, especially among Communist ...

Healthcare professionals, buyers, and industry leaders from across the globe will gather in Bangkok from 10 to 12 September 2025 for MEDICAL FAIR THAILAND 2025—the region’s leading exhibition for ...

It’s not merely the heat – it’s the humidity that poses a lethal threat.Experts warn of a wet-bulb temperature (WBT) threat as Malaysia sweats ...

Mental illness, cardiovascular disease, tobacco use, and injuries are now among the leading causes of death and disability in Southeast Asia, according to newly released research from the Institute ...

Cases of diabetes and high cholesterol levels in Kelantan have seen an increase exceeding the national average indicators, says Health Minister Datuk Seri Dr Dzulkefly Ahmad. He said based on the ...

A new report from global consultancy Kearney and the World Economic Forum’s Global Alliance for Women’s Health—supported by the Gates Foundation—calls for sweeping policy changes to address the ...

Agilent Technologies and Ubix Therapeutics have signed a Memorandum of Understanding (MOU) to accelerate research and development of targeted cancer therapies in South Korea over the next five years.

Malaysian medical graduates are highly sought after by hospitals in Singapore, which consider them to be “cheap yet high quality assets”, according to a Malaysian doctor serving in the city-state.

As Malaysia continues to strengthen its position as Southeast Asia’s hub for healthcare and pharmaceuticals—with strategic alliances and high-level participation across medtech, biopharma, digital ...

Agilent Technologies and Ubix Therapeutics have signed a Memorandum of Understanding (MOU) to accelerate research and development of targeted cancer therapies in South Korea over the next five years.

As Malaysia continues to strengthen its position as Southeast Asia’s hub for healthcare and pharmaceuticals—with strategic alliances and high-level participation across medtech, biopharma, digital ...